Vanda Pharms Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for VANDA PHARMS INC, and what generic alternatives to VANDA PHARMS INC drugs are available?
VANDA PHARMS INC has three approved drugs.
There are thirty US patents protecting VANDA PHARMS INC drugs.
There are two hundred and sixty-five patent family members on VANDA PHARMS INC drugs in thirty-two countries.
Summary for Vanda Pharms Inc
| International Patents: | 265 |
| US Patents: | 30 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Vanda Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | RX | Yes | Yes | 9,539,234 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-002 | May 6, 2009 | RX | Yes | No | 9,072,742 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-006 | May 6, 2009 | RX | Yes | No | 8,586,610 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-002 | May 6, 2009 | RX | Yes | No | 8,999,638 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-007 | May 6, 2009 | RX | Yes | No | 8,586,610 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-003 | May 6, 2009 | RX | Yes | No | 8,586,610 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vanda Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-001 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
| Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | 5,856,529 | ⤷ Try a Trial |
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-005 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-002 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-004 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
| Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | 5,856,529 | ⤷ Try a Trial |
| Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-007 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VANDA PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, & 12 mg | ➤ Subscribe | 2013-05-06 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2018-01-31 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2018-01-31 |
International Patents for Vanda Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5692872 | ⤷ Try a Trial |
| Canada | 2893542 | ⤷ Try a Trial |
| Canada | 2274183 | ⤷ Try a Trial |
| Colombia | 7131353 | ⤷ Try a Trial |
| South Korea | 20190040102 | ⤷ Try a Trial |
| Brazil | 112017003644 | ⤷ Try a Trial |
| Japan | 2016506410 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
